Erasca Ownership | Who Owns Erasca?
Erasca Ownership Summary
Erasca is owned by 82.17% institutional investors, 12.39% insiders, and 5.44% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 7.45% of ERAS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Erasca shares.
ERAS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Erasca | 82.17% | 12.39% | 5.44% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Frazier life sciences management | 16.22M | 7.45% | $38.27M |
Vr adviser | 16.22M | 7.45% | $38.27M |
Blackrock | 10.61M | 7.02% | $25.04M |
Vanguard group | 10.35M | 6.85% | $24.43M |
Suvretta capital management | 13.77M | 6.32% | $32.49M |
Arch venture management | 11.06M | 5.08% | $26.09M |
Artal group | 9.63M | 4.42% | $22.73M |
Janus henderson group | 8.18M | 3.75% | $19.34M |
Silverarc capital management | 7.82M | 3.59% | $18.45M |
T. rowe price investment management | 7.37M | 3.39% | $17.40M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Arch venture management | 11.06M | 9.81% | $26.09M |
Silverarc capital management | 7.82M | 4.35% | $18.45M |
5am venture management | 5.41M | 2.85% | $12.76M |
Vr adviser | 16.22M | 2.44% | $38.27M |
Edbi pte | 888.89K | 2.37% | $2.10M |
Prosight management, lp | 2.75M | 1.94% | $6.49M |
Sio capital management | 2.87M | 1.84% | $6.78M |
Frazier life sciences management | 16.22M | 1.79% | $38.27M |
Vivo capital | 6.76M | 1.47% | $15.95M |
Suvretta capital management | 13.77M | 1.19% | $32.49M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Frazier life sciences management | 16.22M | 1.79% | 16.22M |
Vr adviser | 16.22M | 2.44% | 16.22M |
Suvretta capital management | 13.77M | 1.19% | 13.77M |
Janus henderson group | 8.18M | 0.01% | 8.18M |
Silverarc capital management | 7.82M | 4.35% | 7.59M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Armistice capital | - | - | -6.17M |
Balyasny asset management | - | - | -4.32M |
Schroder investment management group | - | - | -1.93M |
Cvi | - | - | -1.46M |
Exoduspoint capital management, lp | - | - | -1.19M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Frazier life sciences management | 16.22M | 1.79% | 16.22M | $38.27M |
Vr adviser | 16.22M | 2.44% | 16.22M | $38.27M |
Suvretta capital management | 13.77M | 1.19% | 13.77M | $32.49M |
T. rowe price investment management | 7.37M | 0.01% | 7.37M | $17.40M |
Paradigm biocapital advisors lp | 7.25M | 0.65% | 7.25M | $17.11M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -18.00 |
Gps wealth strategies group | -350.00 |
Eversource wealth advisors | -610.00 |
Allworth financial lp | -1.25K |
Metropolitan life insurance co/ny | -1.53K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 134 | 5.51% | 232,039,374 | 13.99% | 82 | 0.94% | 78 | -13.33% | 29 | 26.09% |
Jun 30, 2024 | 127 | 15.45% | 203,567,433 | 180.08% | 93 | 4.04% | 90 | 87.50% | 23 | -47.73% |
Mar 31, 2024 | 110 | -7.56% | 72,682,320 | 4.96% | 48 | 2.26% | 48 | -30.43% | 44 | 33.33% |
Dec 31, 2023 | 119 | 8.18% | 69,248,421 | -2.85% | 46 | 2.05% | 69 | 21.05% | 33 | 17.86% |
Sep 30, 2023 | 110 | -0.90% | 71,280,157 | -4.07% | 47 | 1.93% | 57 | -1.72% | 28 | 7.69% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 7.15M | 2.53% | -768.36K |
iShares Russell 2000 ETF | 4.44M | 1.57% | -9.98K |
T. Rowe Price Small-Cap Value | 4.20M | 1.49% | 1.46K |
T. Rowe Price US Small-Cap Core Equity | 3.64M | 1.29% | 3.64M |
T. Rowe Price Small-Cap Stock | 3.64M | 1.29% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 3.30M | 1.17% | -11.31K |
T. Rowe Price U.S. SC Value Eq Tr-Z | 2.64M | 0.94% | 540.74K |
SPDR® S&P Biotech ETF | 2.56M | 0.91% | 28.35K |
T. Rowe Price U.S. SC Core Eq Tr-Z | 1.78M | 0.63% | 1.78M |
T. Rowe Price Instl Small-Cap Stock | 1.78M | 0.63% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 21, 2024 | Casdin Alexander W. | - | Buy | $181.92K |
Dec 06, 2023 | Start Valerie Denise Harding | - | Buy | $18.48K |
Dec 05, 2023 | Lim Jonathan E | Chairman & CEO | Buy | $1.22M |
Dec 06, 2023 | Lim Jonathan E | Chairman & CEO | Buy | $478.42K |
Dec 04, 2023 | Casdin Alexander W. | - | Buy | $49.78K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 1 | - |
2024 Q1 | - | - |
2023 Q4 | 5 | - |
2023 Q2 | 2 | - |
2023 Q1 | 2 | - |
ERAS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools